Myostatin Gene Polymorphism in an Elderly Sarcopenic Turkish Population

Genetic Testing and Molecular Biomarkers

Volumn 19, Issue 8, 2015, Pages 457-460

  Tosun Tasar, Pinar ^a   Sahin, Sevnaz ^a   Karaman, Emine ^b   Oz, Atilla ^a   Ulusoy, Merve Gulsah ^a   Duman, Soner ^a   Berdeli, Afig ^a   Akcicek, Fehmi ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MYOSTATIN; MSTN PROTEIN, HUMAN;

AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE MUTATION; GENOTYPE; GERIATRIC PATIENT; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOPENIA; TURK (PEOPLE); VERY ELDERLY; BLOOD; CAUCASIAN; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETICS; TURKEY;

AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MYOSTATIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SARCOPENIA; SEQUENCE ANALYSIS, DNA; TURKEY;

EID: 84938384441     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2015.0033     Document Type: Article

References (20)

1. Allen DL, Unterman TG (2007) Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 292: C188-C199.
2. Bhatt SP, Nigam P, Misra A, et al. (2012) Association of the Myostatin gene with obesity, abdominal obesity and low lean body mass and in non-diabetic Asian Indians in north India. PLoS One 7: e40977.
3. Cesari M, Fielding RA, Pahor M, et al. (2012) Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle 3: 181-190.
4. Corsi AM, Ferrucci L, Gozzini A, et al. (2002) Myostatin polymorphisms and age-related sarcopenia in the Italian population. J Am Geriatr Soc 50: 1463.
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
6. Ferrell RE, Conte V, Lawrence EC, et al. (1999) Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 62: 203-207.
7. Garatachea N, Lucia A (2013) Genes and the ageing muscle: A review on genetic association studies. Age (Dordr) 35: 207-233.
8. Gonzalez-Freire M, Rodriguez-Romo G, Santiago C, et al. (2010) The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan. Age (Dordr) 32: 405-409.
9. Huygens W, Thomis MA, Peeters MW, et al. (2004) Linkage of myostatin pathway genes with knee strength in humans. Physiol Genomics 17: 264-270.
10. Jiang MS, Liang LF, Wang S, et al. (2004) Characterization and identification of the inhibitory domain of GDF-8 propeptide. Biochem Biophys Res Commun 315: 525-531.
11. Kostek MA, Angelopoulos TJ, Clarkson PM, et al. (2009) Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. Med Sci Sports Exerc 41: 1063-1071.
12. Lee SJ, McPherron AC (2001) Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 98: 9306-9311.
13. Li X, Wang SJ, Tan SC, et al. (2014) The A55T and K153R polymorphisms of MSTN gene are associated with the strength training-induced muscle hypertrophy among Han Chinese men. J Sports Sci 32: 883-891.
14. McPherron AC, Lawler AM, Lee SJ (1997) Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 38783-90.
15. Nishiyama A, Takeshima Y, Saiki K, et al. (2007) Two novel missense mutations in the myostatin gene identified in Japanese patients with Duchenne muscular dystrophy. BMC Med Genet 8: 19.
16. Rios R, Fernandez-Nocelos S, Carneiro I, et al. (2004) Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology 145: 2795-2803.
17. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127: 990S-991S.
18. Santiago C, Ruiz JR, Rodriguez-Romo G, et al. (2011) The K153R polymorphism in the myostatin gene and muscle power phenotypes in young, non-athletic men. PLoS One 6: e16323.
19. Thomis MA, Huygens W, Heuninckx S, et al. (2004) Exploration of myostatin polymorphisms and the angiotensinconverting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur J Appl Physiol 92: 267-274.
20. Yu R, Wong M, Leung J, et al. (2014) Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int 14 Suppl 1: 15-28.